The recent crop of new stocks runs the gamut from R&D stage biotech to a Fortune 500 spin-off with billions in revenue.
News & Analysis: Danaher
These moves could help you make money in a downturn.
The economy may be slowing but there are still pockets of growth for investors to exploit.
The stock is a safe place to hide in an uncertain environment.
DHR earnings call for the period ending July 18, 2019.
Another strong year and a transformational acquisition are in progress for one of the most admired industrial companies in the U.S.
Here's what makes Roper Technologies and Danaher so special in the stock market.
Danaher's management continues to transform the conglomerate, and the GE Biopharma deal looks like an even better value after a recent disclosure.
The global science and technology company beat expectations in Q1. However, a pending acquisition caused Danaher to cut its full-year outlook.
DHR earnings call for the period ending March 29, 2019.